FDA Neurology Panel Will Review MTI Onyx PMA Based On Coil Comparison
This article was originally published in The Gray Sheet
Executive Summary
FDA's Neurological Devices Advisory Panel will meet Aug. 5 to review Micro Therapeutics' PMA for Onyx liquid embolic polymer to treat arteriovenous malformations (AVM)